Gary A. Lyons - 21 May 2026 Form 4 Insider Report for NEUROCRINE BIOSCIENCES INC (NBIX)

Reporting relationship: Director
Issuer ticker: NBIX
Reported as of: 21 May 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 May 2026, 19:21:01 UTC
Prior SEC filing: 21 May 2026
Next SEC filing: 29 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Darin Lippoldt, Attorney-in-Fact

Key filing fact

Gary A. Lyons filed Form 4 for NEUROCRINE BIOSCIENCES INC (NBIX) on 21 May 2026.

Key facts

This page summarizes Gary A. Lyons's Form 4 filing for NEUROCRINE BIOSCIENCES INC (NBIX).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 21 May 2026, 19:21.

Change

Previous filing in this sequence was filed on 21 May 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001123343 Primary reporting owner

LYONS GARY A

Relationship: Director
Address: 6027 EDGEWOOD BEND CT., SAN DIEGO
Signature: /s/ Darin Lippoldt, Attorney-in-Fact
Signature date: 21 May 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NBIX transaction

Common Stock

Options Exercise

Transaction value
Shares: +1,659
Change %: +1.4%
Price: $0.000000^*
Shares after: 122,141
Date: 21 May 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NBIX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
Shares: -1,659
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 21 May 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 1,659
Exercise price: $0.000000
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

116,158 of the reported shares are held by the Gary A. Lyons Revocable Living Trust U/A 6/8/12, of which the Reporting Person has voting and investment power

Footnote F2

Each Restricted Stock Unit ("RSU") represents the right to receive one share of the Issuer's common stock upon vesting.

Footnote F3

This RSU award was granted to the Reporting Person on May 21, 2025 and is fully vested.